[go: up one dir, main page]

  • Typical Retirement Savings By Age Groups: Are Yours Bigger?
    Investor's Business Daily

    Typical Retirement Savings By Age Groups: Are Yours Bigger?

    Are your IRA and 401(k) balances as big as retirement savings by other people your age? Bigger? If yours are smaller, here are tips for saving more.

  • MarketWatch

    Dow down 414 points on losses for American Express, UnitedHealth stocks

    DOW UPDATE Dragged down by losses for shares of American Express and UnitedHealth, the Dow Jones Industrial Average is in a selloff Monday morning. The Dow (DJIA) was most recently trading 414 points lower (-1.

  • Coronavirus and Mideast tensions aren’t the stock market’s biggest problems this week, strategist warns

    Coronavirus and Mideast tensions aren’t the stock market’s biggest problems this week, strategist warns

    Longtime stock-market bull and National Securities strategist Art Hogan shared his bearish stance in a CNBC interview ahead of what looks to be a busy week of trading. He says the S&P 500 could see a pullback of as much as 5%.

  • TheStreet.com

    Afghanistan Plane Crash Unlikely Linked to Boeing; US Military Investigating

    Media reports had suggested a Boeing-made 737-400, carrying 83 passengers, crashed shortly after takeoff some 181 kilometers south of the Afghanistan capital of Kabul.

  • Investopedia

    Apple Stock Could Enter Multi-Month Correction

    Apple shares could sell off in coming weeks, entering a correction that shakes out the enormous supply of weak hands.

  • Dow Jones Futures Plunge As Coronavirus Spreads Rapidly; Apple, Tesla Lead Huge Earnings Week
    Investor's Business Daily

    Dow Jones Futures Plunge As Coronavirus Spreads Rapidly; Apple, Tesla Lead Huge Earnings Week

    Stock futures plunged as coronavirus fears hit the stock market rally. Apple earnings are on tap this week. So are AMD, Facebook, Microsoft and Tesla earnings

  • One of the most successful stock-market investors says these 3 events ‘would definitely trigger a bear market’

    One of the most successful stock-market investors says these 3 events ‘would definitely trigger a bear market’

    Stanley Druckenmiller, one of Wall Street’s most successful investors, acknowledges that the markets are riding high and that investors may be able to finally breathe in the short term after a number of shocks, but says investors should be wary of three events that could knock assets into a bear market.

  • Analysts: 2 Big 8% Dividend Stocks to Buy (And 1 to Sell)

    Analysts: 2 Big 8% Dividend Stocks to Buy (And 1 to Sell)

    We’re coming off a year of major-league gains in the markets, and analysts are predicting a flatter year ahead. With the strong likelihood that share price returns will slow down, now is a logical time to start reassessing your portfolio. It’s time to decide which stocks to shed, and which to snap up.Income is the deciding factor. Investing is all about making money, making your investments grow. So, if markets follow the predictions, and growth slows, that leaves dividends as the sensible route to go. Dividends provide a steady income stream, whether markets go up or down. But not all dividend stocks are created equal.With that in mind, we delved into the market data from TipRanks.com to get the lowdown on 3 high-yield dividend stocks, two of which analysts think are set to shine in 2020, and one whose prospects aren’t quite as bright. Let’s dive in:Viper Energy Partners (VNOM)We’ll start with the cash-rich energy industry. Specifically, with Viper Energy, an oil company operating in the Midland formation of the Texas Permian Basin. This basin holds the largest proven oil reserves in North America, and operations in the Permian have made the US the world’s largest producer of crude oil. Viper has exploration rights in more than 14,000 acres in the Midland, which are exploited by third parties and subsidiaries who then pay the royalties that make up Viper’s income. Viper Energy’s land holdings contain an estimated 10 billion barrels of recoverable oil and oil equivalents.Despite low oil prices, Viper’s position as a land holder rather than direct operator allowed it to continue recording profits in 2H19. At the same time, lower forward guidance pushed the stock price down. The top- and bottom-line numbers in Q3 – the last reported – disappointed; revenues missed the forecast by 6% and came in at $71.8 million, while EPS, at 13 cents, missed the estimate by only a penny. At the same time, EPS was up 160% year-over-year, and oil production showed a 9% sequential gain.Better for investors, Viper has held fast to its dividend commitment. The company is consistent about making the payments, and has a history of adjusting the payment to make sure that it is sustainable. Currently, VNOM shares pay out a quarterly dividend of 46 cents, or $1.84 annually, giving a yield of 8.21%. This is more than four times the average yield found among S&P 500 stocks.Viper’s production has been strong in recent months, and Wall Street analysts are taking notice. Pearce Hammond, of Piper Sandler, writes, “Positive news for VNOM as the company announced Q4'19 total production of 26.1 Mboe/d which bested our estimate by 2%… Taking into account increased equity unit count, VNOM increased production per million partnership units outstanding by ~5% q/q despite the headwinds of a broad activity slowdown on non-operated properties in Q4.” Hammond puts a Buy rating on the stock, along with a price target of $33, indicating an upside potential of 47%. (To watch Hammond’s track record, click here)Also bullish is Welles Fitzpatrick from SunTrust Robinson. Fitzpatrick notes the strategic implications of Viper’s more recent land acquisitions: “While the company has been extremely active on the acquisition front, as of the last update interest had gone down somewhat. Instead we expect the company to refrain from adding acreage that it cannot reasonably predict activity plans for, a move that we think will be rewarded by the currently more conservative energy investor base.” Fitzpatrick backs his Buy rating with a $32 price target, showing confidence in an upside of 42%. (To watch Fitzpatrick’s track record, click here)Overall, Wall Street likes VNOM shares. In fact, the analyst consensus on this stock is a unanimous Strong Buy, with 9 positive reviews. Shares are selling for $22.04, and the average price target of $33.67 suggests an impressive 50% upside potential. (See Viper stock analysis at TipRanks)Hercules Capital (HTGC)Venture capital is the lifeblood of innovation. Start-ups couldn’t start without money, and all new research and development has to be paid for. Venture firms are a major vehicle for injecting private money into the business world. Hercules Capital inhabits that niche, and to date has committed $10 billion to the life sciences, technology, and financial SaaS sectors.Venture capitalists are necessary for innovators to succeed, but they don’t operate as a charity. They want to see a return on their money. Hercules has been fortunate, and its investments have provided strong returns. In Q3, the most recent report on record, the company showed a record in net investment income of $38.9 million, which came out to 37 cents per share. For the 12 months ending on September 30, the company showed a total of $103.2 million net investment income, or $1.03 per share. In three of the past four quarter reported, HTGC has beating the earnings forecasts.The company has also grown its dividend. After holding the payment steady at 31 cents from 2013 to 2018, HTGC began increasing the payout, raising it three times in 2019. The current payment, 35 cents, annualizes to $1.40, for a yield of 8.9%. It’s a clear boon for investors.Writing for Jefferies, 5-star analyst John Hecht points out the generally strong position of HTGC stock: “We observe positive trends and developments at HTGC, and we believe this reflects inherent competitive advantages and strong execution. Additionally, we point to an ongoing strong VC market backdrop and further enhanced balance sheet…”Hecht maintains a Buy rating here, and puts a $16 price target on HTGC. His target suggests room for 11% upside growth in this stock. (To watch Hecht’s track record, click here)HTGC is another company with a unanimous analyst consensus of Strong Buy, this one based on 4 Buy ratings. Shares sell for $14.30, and the average price target of $15.33 implies a modest upside of 6.6%. The key point here is the high dividend. (See Hercules Capital’s stock analysis at TipRanks)Macy’s, Inc. (M)Macy’s is a storied name in American retail, a long-time mainstay of the department store segment. Before the decline of indoor shopping malls, there was a time when Macy’s stores were frequently seen as anchors for the country’s retail shopping outlets. But times have been hard for American retail. Since 2015, Macy’s has closed more than 150 under-performing locations.In the most recent quarterly report, for third quarter 2019, M showed the first same-store sales decline in two years. The drop was 3.5%, and came in hand with a fall-off in revenue of 4.25%, to $5.17 billion. EPS did beat expectations, however, coming in at 7 cents versus the breakeven forecast. On the downside, that was a 65% drop year-over-year.Falling earnings and a gloomy long-term outlook for brick-and-mortar retail have this stock on the ropes for now – but Macy’s is still paying out the dividend. At 37.75 cents per quarter, it annualizes to $1.51, and gives the highest yield on this list, of 9%. It’s a solid performance, but unless the EPS moves back up, it may not be sustainable.Top analysts are not sanguine about the future for Macy’s. From Credit Suisse, 4-star analyst Michael Binetti writes, “[W]e think negative -0.6% SSS and -3% YOY gross profit dollar declines in a booming economy offer little evidence so far of a change in the ultimate medium and long-term challenges facing the company. Importantly, we still have little visibility on how EBIT margins can stabilize from here… We continue to believe it’s going to be increasingly difficult for the stock to stabilize on valuation alone.”Binetti puts a $12 target on M stock, implying a 28% downside for the shares. This is inline with his Sell rating, and his believe that the stock will underperform in coming months. (To watch Binetti’s track record, click here)Kimberly Green, 5-star analyst with Morgan Stanley, is also bearish here. She writes, “Despite closing stores proactively, store-only comps remain negative and we forecast them to remain so in the future, eroding ROIC. Expense cuts, real estate monetization, and secondary growth initiatives are encouraging, but we think the market needs to see core retail EBIT stabilization and a return to strong cash flow generation in order to become more constructive on the stock.”Green’s price target is slightly higher than Binetti’s, at $13, but even that implies a downside of 22.5%. Again, this is in-line with her Sell rating. (To watch Green’s track record, click here)The analysts clear on this stock: the consensus rating here is a Moderate Sell, based on 6 Sells, 5 Holds, and just 1 Buy. Despite the high dividend, Wall Street does not see this as a strong market play. Shares are selling for $16.78, but the average price target is $15.40, suggesting the stock will slip 8% in the next year.

  • TheStreet.com

    Coronavirus, Dow Futures Plunge, Google and Kobe Bryant - 5 Things You Must Know Monday

    Stock futures sink as investors weigh the human and economic costs of the accelerating spread of the deadly coronavirus; Apple, Facebook, Microsoft and Amazon report earnings this week; basketball legend Kobe Bryant dies in a helicopter crash.

  • Want to solve the retirement crisis? Invest $7,500 for every baby born in America

    Want to solve the retirement crisis? Invest $7,500 for every baby born in America

    A one-time $7,500 contribution at birth could potentially change everything for a future retiree. Many Americans haven’t saved enough for retirement, and end up relying on Social Security to fund their old age. For some, Social Security makes up 90% of their retirement income.

  • This basket of dividend growth stocks can help your portfolio stand out in 2020

    This basket of dividend growth stocks can help your portfolio stand out in 2020

    These stocks have low price-to-earnings valuations relative to the S&P 500 that also appear likely to continue raising their dividend payouts more quickly than the broad market.

  • MarketWatch

    All 30 Dow stocks are falling, with Apple and Boeing the biggest drags

    All 30 of the Dow Jones Industrial Average's components are falling in premarket trading Monday, as the anxiety grows over the spreading of the corovnavirus that originated from China. Dow future tumbled 424 points. The biggest drags on the Dow, which is a price-weighted index, are the selloffs in the shares of Apple Inc. and Boeing Co. . Apple's stock fell 2.5%, while the implied price decline was shaving about 54 points off the Dow's price. Boeing's stock dropped 2.2%, and was reducing the Dow's price by about 48 points. There have been reports about events surrounding a Boeing-built plane in Afghanistan, but the company has not immediately responded to a request for comment.

  • Roth IRA Contributions with No Job?

    Roth IRA Contributions with No Job?

    Even if you don't have a conventional job, you may be able to contribute to a Roth IRA, using these unconventional income sources.

  • MarketWatch

    Marathon Petroleum raises dividend, pushing yield above energy-sector peer group

    Marathon Petroleum Corp. said Monday it will raise it quarterly dividend by 9.4%, to 58 cents a share from 53 cents. The stock was still inactive in premarket trading. The new dividend will be payable March 10 to shareholders of record on Feb. 19. Based on Friday's stock closing price of $54.49, the new annual dividend rate implies a dividend yield that rises to 4.26% from 3.89%. In comparison, the SPDR Energy Select Sector ETF's dividend yield as of Friday was 3.96% and the implied yield for the S&P 500 was 1.82%, according to FactSet. Marathon Petroleum's stock has tumbled 19.9% over the past three months, while the energy ETF has lost 4.9% and the S&P 500 has gained 9.0%.

  • Barrons.com

    Coronavirus Fears Are Hitting the Dow Hard. Travel Stocks Like Delta, Chip Makers, Are Plunging.

    U.S. stocks slumped as investors evaluate the latest news about China’s coronavirus outbreak. Haven investments such as gold are getting a boost.

  • Financial Times

    Fidelity chief on becoming the fund house to fear

    When Fidelity International moved into its new London headquarters last year, chief executive Anne Richards spotted a problem. Ms Richards’ phone and computer are typically found on a desk in the open-plan floor where her investment colleagues sit. An engineer by training, who once applied to be an astronaut, Ms Richards is interested in the geeky aspects of the investments business.

  • The stock market is overvalued: Allianz CEO Oliver Bate
    Yahoo Finance

    The stock market is overvalued: Allianz CEO Oliver Bate

    Allianz CEO Oliver Bate weighs in with his market outlook at the World Economic Forum in Davos.

  • Ford Focus, Fiesta owners get transmission settlement that could top $100M

    Ford Focus, Fiesta owners get transmission settlement that could top $100M

    Ford has settled a class-action lawsuit with nearly 2 million owners and ex-owners of Focus and Fiesta cars with bad dual-clutch transmissions

  • Barrons.com

    What a Boeing Supplier's Earnings Say About the 737 MAX Supply Chain

    Arconic reported earnings Monday morning. 2020 guidance missed Wall Street expectations. The news is an early example of how Boeing’s 737 MAX woes might impact the supply chain in 2020.

  • Mortgage Rates Slide Again and Head Toward All-Time Lows

    Mortgage Rates Slide Again and Head Toward All-Time Lows

    Mortgage rates are lower this week and are closing in on record territory.

  • Barrons.com

    Pfizer Reports Earnings Tomorrow. Here’s What to Expect.

    Analysts expect fourth quarter sales of $12.6 billion, according to FactSet, and quarterly earnings per share of $0.58.

  • MarketWatch

    Allergan to divest two drugs, to move forward with AbbVie deal

    Shares of AbbVie Inc. were up 2% in trading on Monday morning after the drugmaker said Allergan , which it is in the process of acquiring, plans to divest two therapies. Allergan's stock is up 1%. It is selling brazikumab, an experimental Crohn's disease and ulcerative colitis treatment, to AstraZeneca and pancreatic treatment Zenpep to Nestlé. The divestitures are required for AbbVie to move forward with the $63 billion Allergan acquisition, which is expected to close this quarter. AbbVie's stock is up 3% over the last 52 weeks, while Allergan's stock has gained 18% during the same time frame. The Health Care Select Sector SPDR Fund has climbed 15% over the last year.

  • American City Business Journals

    The happiest employers in Silicon Valley, according to the Blind app

    A recent survey by Blind asked two questions: “In 2019, how much growth do you think you had while working at your organization?” and “Are you happy at your current workplace?”